U.S. hospital emergency department visits declined by an estimated 42% between March 29 and April 25 compared to a year ago, while visits for infectious disease screening or exposure were nearly four times higher, according to a released today by the Centers for Disease Control and Prevention.

Overall ED visits declined to a weekly average of 1.2 million from 2.1 million the same period last year, based on data from hospitals in 47 states representing 73% of ED visits.

鈥淭he striking decline in ED visits nationwide, with the highest declines in regions where the pandemic was most severe in April 2020, suggests that the pandemic has altered the use of the ED by the public,鈥 the authors said. 鈥淧ersons who use the ED as a safety net because they lack access to primary care and telemedicine might be disproportionately affected if they avoid seeking care because of concerns about the infection risk in the ED.鈥

To minimize SARS-CoV-2 transmission risk and address public concerns about visiting the ED during the pandemic, the report recommends continued use of virtual visits and triage help lines and adherence to CDC infection control guidance.

Related News Articles

Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium鈥
Headline
 The Food and Drug Administration July 10 approved Moderna鈥檚 Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that鈥
Headline
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational鈥
Headline
The Alliance for Innovation on Maternal Health, with support from the Health Resources and Services Administration, will host a five-part learning series鈥
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention鈥
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England鈥